Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francjan J van Spronsen

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Journal of Inherited Metabolic Disease|February 25, 2011
Mild hyperphenylalaninemia: to treat or not to treatFrancjan J van Spronsen
Molecular Genetics and Metabolism|April 6, 2010
Phenylketonuria management from an European perspective: a commentaryFrancjan J van Spronsen
Nature Reviews. Endocrinology|August 20, 2010
Phenylketonuria: a 21st century perspectiveFrancjan J van Spronsen
Molecular Genetics and Metabolism|February 4, 2010
Future treatment strategies in phenylketonuriaFrancjan J van Spronsen, Gregory M Enns
Lancet (London, England)|April 19, 2014
Recombinant phenylalanine ammonia lyase in phenylketonuriaFrancjan J van Spronsen, Terry G J Derks
Lancet (London, England)|October 26, 2010
PhenylketonuriaNenad Blau, Francjan J van Spronsen, Harvey L Levy
Journal of Inherited Metabolic Disease|August 3, 2019
Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approachRoeland A F Evers, Danique van Vliet, Francjan J van Spronsen
Advances in Experimental Medicine and Biology|July 30, 2017
Liver Cancer in Tyrosinemia Type 1Willem G van Ginkel, Jan P Pennings, Francjan J van Spronsen
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2009
[The right medicine for cerebrotendinous xanthomatosis]Aad Verrips, Ron A Wevers, Francjan J van Spronsen, et al.
Orphanet Journal of Rare Diseases|November 11, 2025
The influence of professionals' personal views and values in the development of guidelines for rare diseases: an example from phenylketonuriaAnnemiek M J van Wegberg, Cristina Romani, Francjan J van Spronsen
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Journal of Inherited Metabolic Disease|February 25, 2011
Mild hyperphenylalaninemia: to treat or not to treatFrancjan J van Spronsen
Molecular Genetics and Metabolism|April 6, 2010
Phenylketonuria management from an European perspective: a commentaryFrancjan J van Spronsen
Nature Reviews. Endocrinology|August 20, 2010
Phenylketonuria: a 21st century perspectiveFrancjan J van Spronsen
Molecular Genetics and Metabolism|February 4, 2010
Future treatment strategies in phenylketonuriaFrancjan J van Spronsen, Gregory M Enns
Lancet (London, England)|April 19, 2014
Recombinant phenylalanine ammonia lyase in phenylketonuriaFrancjan J van Spronsen, Terry G J Derks
Lancet (London, England)|October 26, 2010
PhenylketonuriaNenad Blau, Francjan J van Spronsen, Harvey L Levy
Journal of Inherited Metabolic Disease|August 3, 2019
Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approachRoeland A F Evers, Danique van Vliet, Francjan J van Spronsen
Advances in Experimental Medicine and Biology|July 30, 2017
Liver Cancer in Tyrosinemia Type 1Willem G van Ginkel, Jan P Pennings, Francjan J van Spronsen
Nederlands Tijdschrift Voor Geneeskunde|May 21, 2009
[The right medicine for cerebrotendinous xanthomatosis]Aad Verrips, Ron A Wevers, Francjan J van Spronsen, et al.
Orphanet Journal of Rare Diseases|November 11, 2025
The influence of professionals' personal views and values in the development of guidelines for rare diseases: an example from phenylketonuriaAnnemiek M J van Wegberg, Cristina Romani, Francjan J van Spronsen
Pageof 17